Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 331 AL 345

A decade of Alzheimer's Research & Therapy: reflections on the past, present, and future

Galasko D, Scheltens P.

Alzheimers Res Ther. 2020 May 30;12(1):67. doi: 10.1186/s13195-020-00629-y.

Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease

Uddin MS, Al Mamun A, Rahman MA, Behl T, Perveen A, Hafeez A, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

Curr Top Med Chem. 2020;20(26):2380-2390. doi: 10.2174/1568026620666200601161703.

DNA methylation in the pathology of Alzheimer's disease: from gene to cognition

Poon CH, Tse LSR, Lim LW.

Ann N Y Acad Sci. 2020 Sep;1475(1):15-33. doi: 10.1111/nyas.14373. Epub 2020 Jun 3.

Brain Structure in Bilingual Compared to Monolingual Individuals with Alzheimer's Disease: Proof of Concept

Raji CA, Meysami S, Merrill DA, Porter VR, Mendez MF.

J Alzheimers Dis. 2020;76(1):275-280. doi: 10.3233/JAD-200200.

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

Mamun AA, Uddin MS, Bin Bashar MF, Zaman S, Begum Y, Bulbul IJ, Islam MS, Sarwar MS, Mathew B, Amran MS, Md Ashraf G, Bin-Jumah MN, Mousa SA, Abdel-Daim MM.

Oxid Med Cell Longev. 2020 May 15;2020:5086250. doi: 10.1155/2020/5086250. eCollection 2020.

Translational Scoring of Candidate Treatments for Alzheimer's Disease: A Systematic Approach

Cummings JL.

Dement Geriatr Cogn Disord. 2020;49(1):22-37. doi: 10.1159/000507569. Epub 2020 Jun 8.

The Nerve to Give BACE Inhibitors a Second Chance?

Baloh RH.

Neurotherapeutics. 2020 Jul;17(3):966-967. doi: 10.1007/s13311-020-00876-9.

Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential

Sousa JCE, Santana ACF, MagalhÃes GJP.

Arq Neuropsiquiatr. 2020 Jun 8;78(8):501-511. doi: 10.1590/0004-282X20200010.

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease

Cacabelos R.

Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):673-701. doi: 10.1080/17425255.2020.1779700. Epub 2020 Jun 23.

Takotsubo Cardiomyopathy in an Alzheimer Disease Patient: The Potential Contribution of Antidepressant Agents

Moulin Mares SRA, Groner JS, de Oliveira MP, Lírio LV, Coutinho PC, Luchi WM.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):360-361. doi: 10.1097/WAD.0000000000000395.

Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia

Wang S, Temkin-Greener H, Conwell Y, Cai S.

J Am Med Dir Assoc. 2020 Nov;21(11):1617-1622.e3. doi: 10.1016/j.jamda.2020.04.005. Epub 2020 Jun 9.

Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential

Ding XW, Li R, Geetha T, Tao YX, Babu JR.

Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165858. doi: 10.1016/j.bbadis.2020.165858. Epub 2020 Jun 10.

Shifting paradigms: The central role of microglia in Alzheimer's disease

Schwabe T, Srinivasan K, Rhinn H.

Neurobiol Dis. 2020 Sep;143:104962. doi: 10.1016/j.nbd.2020.104962. Epub 2020 Jun 12.

Crosstalk between obesity, diabetes, and alzheimer's disease: Introducing quercetin as an effective triple herbal medicine

Ebrahimpour S, Zakeri M, Esmaeili A.

Ageing Res Rev. 2020 Sep;62:101095. doi: 10.1016/j.arr.2020.101095. Epub 2020 Jun 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias